Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 1.43% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Fix not verifiedUnspecified vulnerability in the WebLogic Server component in BEA Product Suite 10.3, 10.0 MP1, 9.2 MP3, 9.1, 9.0, 8.1 SP6, 7.0, and SP7 allows remote attackers to affect confidentiality, integrity, and availability, related to WLS. NOTE: the previous information was obtained from the January 2009 CPU. Oracle has not commented on reliable researcher claims that this issue is cross-site scripting.
Unspecified vulnerability in the WebLogic Server component in BEA Product Suite 10.3, 10.0 MP1, 9.2 MP3, 9.1, 9.0, 8.1 SP6, 7.0, and SP7 allows remote attackers to affect confidentiality, integrity, and availability, related to WLS. NOTE: the previous information was obtained from the January 2009 CPU. Oracle has not commented on reliable researcher claims that this issue is cross-site scripting.
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
Unspecified vulnerability in the WebLogic Server component in BEA Product Suite 10.3, 10.0 MP1, 9.2 MP3, 9.1, 9.0, 8.1 SP6, 7.0, and SP7 allows remote attackers to affect confidentiality, integrity, and availability, related to WLS. NOTE: the previous information was obtained from the January 2009 CPU. Oracle has not commented on reliable researcher claims that this issue is cross-site scripting.
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-200: Exposure of Sensitive Information to an Unauthorized Actor. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
AV:N/AC:M/Au:N/C:P/I:P/A:POperational remediation based on structured source evidence.
Published 14 Jan 2009 · Last source change 7 Aug 2024, 10:56 UTC · CWE-200 · Exposure of Sensitive Information to an Unauthorized Actor
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.